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Abstract
Background: Red flags are signs and symptoms that are possible indicators of serious spinal pathology. There is
limited evidence or guidance on how red flags should be used in practice. Due to the lack of robust evidence for
many red flags their use has been questioned. The aim was to conduct a systematic review specifically reporting on
studies that evaluated the diagnostic accuracy of red flags for Spinal Infection in patients with low back pain.
Methods: Searches were carried out to identify the literature from inception to March 2019. The databases
searched were Medline, CINHAL Plus, Web of Science, Embase, Cochrane, Pedro, OpenGrey and Grey Literature
Report. Two reviewers screened article texts, one reviewer extracted data and details of each study, a second
reviewer independently checked a random sample of the data extracted.
Results: Forty papers met the eligibility criteria. A total of 2224 cases of spinal infection were identified, of which
1385 (62%) were men and 773 (38%) were women mean age of 55 (± 8) years. In total there were 46 items, 23
determinants and 23 clinical features. Spinal pain (72%) and fever (55%) were the most common clinical features,
Diabetes (18%) and IV drug use (9%) were the most occurring determinants. MRI was the most used radiological
test and Staphylococcus aureus (27%), Mycobacterium tuberculosis (12%) were the most common microorganisms
detected in cases.
Conclusion: The current evidence surrounding red flags for spinal infection remains small, it was not possible to
assess the diagnostic accuracy of red flags for spinal infection, as such, a descriptive review reporting the
characteristics of those presenting with spinal infection was carried out. In our review, spinal infection was common
in those who had conditions associated with immunosuppression. Additionally, the most frequently reported
clinical feature was the classic triad of spinal pain, fever and neurological dysfunction.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non-Commercial
(CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially,
and license their derivative works on different terms, provided the original work is properly cited and the use is
non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
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Background
Medical doctors and, musculoskeletal practitioners such
as Physiotherapists, Osteopaths and Chiropractors have
traditionally used red flags to help in the identification
of patients with serious spinal pathology. There are 163
individual items that could be considered as red flags;
119 items in the patient history and 44 items in the
physical examination (CSP 2007). Clearly, this presents a
problem in terms of the practical clinical utility. In
addition, there is limited evidence or guidance on how
these red flags should be used in practice [1–3]. Due to
the lack of robust evidence for many red flags their use
has been called into question [4, 5]. However, clinicians
still need to decide whether the patient’s problem is suit-
able for immediate conservative management (keep), or
whether the patient needs to be referred for further in-
vestigation (refer). Therefore in spite of no consensus in
either guidelines or research, red flags are still seen as
the most reliable clinical indicator for potential serious
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pathology and remain fundamental to the assessment
process [6].
Although infections of the spine such as extra pul-
monary Tuberculosis (TB) are uncommon, they are on
the rise [7, 8]. The majority of SI are of insidious onset
and commonly there is a prolonged period of time be-
tween onset and diagnosis which can create a complex
clinical picture as patients can remain relatively healthy
until symptoms manifest themselves in the later stages
of the disease [9, 10]. Back pain is the most common
presenting symptom which can progress to neurological
symptoms and if not treated in a timely manner, lead to
serious complications such as paralysis, instability of the
spine and can ultimately be fatal [11–14].
Spinal infection often typically thought of as having a
long prodromal period, however, Sapico and Montgom-
erie [10] report 30% of patients were diagnosed from
three weeks to three months and 20% of patients were
diagnosed in less than three weeks. In cases where there
is a prolonged prodromal period, it is unsurprising that
errors in the diagnosis of SI in back patients are rela-
tively frequent [15]. When it comes to diagnostic errors
in primary care, infection emerges as one of the most
significant categories along with cancer and cardiovascu-
lar disease. The personal and economic consequences of
these errors is significant and are a global burden [16].
For example the legal cost of errors in the diagnosis of
SI in the National Health Service (NHS) in the UK is
considerable. Between 2002 and 2010, SI accounted for
11.6% of all spinal related malpractice litigation, with the
average damage costing the NHS £433,296 per case [17].
These figures are likely to rise, as reported by the Med-
ical Protection Society (MPS). The clinical negligence
costs over the past five years within the NHS increased
by 72% and are projected to rise to £2.6 billion per year
by 2022 [18].
Two of the solutions proposed by the World Health
Organisation (WHO) to reduce the global burden of
diagnostic errors in Primary Care are to improve diag-
nostic reasoning and optimise diagnostic strategies [19].
As such this review provides the basis for the construc-
tion of a robust International evidence-based clinical
framework to improve the identification of patients with
SI. Errors in the diagnosis of SI are reported to be as a
result of two issues, first failure to recognise the relevant
red flags, and second failure to consider SI as a potential
differential diagnosis [20–23]. It is therefore vital that
clinicians are aware of the possible signs and symptoms
of SI and the risk of SI that an individual may have.
When used, this knowledge will help to raise the index
of suspicion and aid in the early identification of SI.
The primary aim of this study was to investigate the
existing evidence to support the use of red flags for iden-
tifying Spinal Infection. Therefore, we searched the
literature and reviewed studies reporting red flags in
Spinal Infection patients.
Methods
This review was registered with the International Pro-
spective Register of Systematic Reviews on 24/11/17
(PROSPERO; http://www.crd.york.ac.uk/prospero, refer-
ence: CRD42017081447). The review was conducted in
concordance with the Prefered Reporting Items for Sys-
tematic Review and Meta-Analysis (PRISMA) guideline
[24]. Our apriori aim was to conduct a systematic review
specifically reporting on studies that evaluated the diag-
nostic accuracy of red flags for SI in patients with low
back pain. Due to the paucity of studies evaluating the
diagnostic accuracy of red flags for SI, unfortunately, it
was not possible to conduct a systematic review on the
diagnostic accuracy of red flags as initially intended,
therefore, a descriptive review reporting on the charac-
teristics of patients with SI was conducted.
Literature search
We searched the following electronic databases from in-
ception to March 2019: Medline, CINHAL Plus, Web of
Science, Embase, Pedro and Cochrane. In addition to
this, OpenGrey and Grey Literature Report were also
searched. The database searches were accompanied by
hand searches of the reference list of included articles
and the grey literature. With the help of the University
librarian a search strategy was set in place, the three key
search terms used were red flag, spinal pain and infec-
tion – see additional file 1 for the search strategy.
Study selection
Studies investigating red flags in SI were included. More
specifically, the eligible studies were study designs and
research articles that had primary data, this included
diagnostic accuracy studies, cohort studies, case-control
studies, and case-series studies. Two reviewers (MY &
LF), independently, screened the eligible papers against
the full article eligibility criteria, any disagreements be-
tween the two reviewers were resolved by a third re-
viewer (JS). Included studies were studies in the English
language that studied adults over the age of 18 who had
a spinal infection, this included Bacterial, Viral, Fungal,
Prionic or Parasitic infections. Further, studies were in-
cluded if they contained primary data such as clinical
tests, diagnostic tests, history taking and/or physical
examination and provided red flags or clinical features
for Spinal Infection. Studies were excluded if they were a
systematic review or a narrative review.
Quality appraisal
Once the full eligible papers were selected, the quality of
the studies was assessed using the National Heart, Lung
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and blood institute (NHLBI) Quality Assessment Tools.
These widely used assessment tools determine the qual-
ity of case-series, case-control and cohort studies.
Data extraction
One reviewer (MY) extracted the data from all the eli-
gible papers. The following data were extracted from
each study: study characteristics, participant characteris-
tics, setting and diagnostic methods, red flags (expo-
sures) and spinal infection (outcomes). After the data
was extracted, 25% of the data was independently
checked by reviewer two (LF), as recommended by the
2009 Updated Method Guidelines for Systematic Re-
views in the Cochrane Back Review Group [25].
Data analysis
Patient data from the included studies were analysed de-
scriptively using frequencies and percentages.
Patient and public involvement
There were no patient or public involvement in any
phase of this study, this included the development of the
research question, the analysis and the conclusions.
Results
The search strategy yielded 2571 eligible papers, further
narrowed down to 2274 papers after duplicates were re-
moved. Once the eligibility criteria for the title and ab-
stract were applied, the total came to 52 papers, of
which 18 were from bibliographic searches. See Fig. 1.
Study selection
After reviewing the 52 eligible papers, 40 papers met the
full eligibility criteria as agreed by the two reviewers (see
additional file 1). One paper was excluded from the review
because it was a narrative review [26], two papers did not
include a description of the testing performed [27, 28] and
Fig. 1 PRISMA 2009 flow diagram
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nine papers were excluded because they did not provide
data for red flags/clinical features for SI [11, 12, 28–35].
The kappa statistics for the agreement between the
two reviewers was k = 0.80, this is considered as ‘Very
good’ [36, 37]. Reviewer three (JS) resolved the disagree-
ment between the first two reviewers, the three discord-
ant papers were included in the study [38–40]. All
disagreements were due to criterion three, whether the
papers provided clinical features for SI.
Characteristic of included papers
For a summary of the main characteristics in each paper,
see additional file 1. Table 1 presents a summary of the
baseline characteristics of the patients in the 40 papers
reviewed. A total of 2224 patients were diagnosed, in-
cluding 1385 male patients (62%) and 773 female pa-
tients (38%) with a mean age of 55 years (SD = 8). In
total, 14 out of 40 papers did not describe or adequately
describe the radiological tests performed. This includes
plain film radiography, ultrasound, magnetic resonance
imaging scan (MRI), gallium scan, bone scan, computed
tomography (CT) scan and myelogram [7, 13, 15, 39,
41–51]. MRI was the most used radiological test with 22
papers using it for investigation. For individual investiga-
tions, Plain radiographs and MRI were the most used
radiological tests. Bone scans and Gallium scans were
the most accurate tests with a positive result of 93 and
90%, respectively. However, ultrasound was the least
sensitive test with a positive result of 21%. Out of all
studies, 34 (85%) were carried out in High-Income coun-
tries and 6 (15%) were carried out in Upper middle-
income countries, none were carried out in Lower
Middle-Income and Lower Income countries.
Red flags
The list of red flags is presented in two groups, determi-
nants and clinical features (Table 2). This decision was
made because of the way in which the papers reported
this information. Determinants were defined as factors
that may play a part in the occurrence of SI, this in-
cluded comorbidities, social factors and sources of infec-
tion that may lead to SI. Within the Dictionary of
Epdimeiology, Last et al. define determinant as:
“a collective or individual risk factor (or set of factors)
that is causally related to a health condition, outcome,
or other defined characteristic. In human health —and,
specifically, in diseases of complex
etiology—determinants often act jointly in relatively
complex and long-term processes. They commonly
Table 1 Study Characteristics
Characteristics Total Sum of papers
No. patients 2224 40
Gender 39
Male (%) 1385 (62.3)
Female (%) 773 (37.7)
Age (mean ± SD) years 55.4 (± 8.2) 35
Data Collection Period (mean ± SD) years 8 (± 4) 40
Diagnostic Tests positive/performed (%)
Plain Radiograph 599/773 (77.5) 14
MRI 505/632 (80.0) 22
CT Scan 342/395 (86.6) 15
Bone Scan 215/232 (92.7) 11
Gallium Scan 65/72 (90.3) 5
Myelogram 39/46 (84.5) 3
Ultrasound 8/39 (20.5) 3
Laboratory tests* 2322/3867 (60.0) 33
Surgery 93/112 (83.0) 6
World Bank Classification by income (%) 40
High Income (HI) 34 (85.0)
Upper Middle Income (UMI) 6 (15.0)
Lower Middle Income (LMI) 0
Lower Income (LI) 0
*Tests included are white blood cell count (WBC), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), pus culture, blood culture and biopsy
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operate at aggregate (e.g., social, regional, global) levels,
as well as at the individual, personal level..” [52].
Adapted from the Myriam-webster dictionary, clinical
features were characterised as observable and diagnos-
able symptoms [53] that may occur as a consequence of
SI. Here we can consider determinants as a priori red
flags leading to the development of SI, and the a poster-
iori as the the signs symptoms and clinical features that
are present after the onset of SI.
In total there were 46 items, 23 determinants and
23 clinical features. For convenience and ease of use
from a clinical perspective, the data were aggregated
into relevant groups. The most frequently reported
determinants were Diabetes (18%), Intravenous drug
use (9%) and Surgery (6%) and the most frequently
reported clinical features were Spinal Pain (72%),
fever (55%) and Neurological Dysfunction (33%).
Other salient red flags were immunosuppression (3%),
invasive procedures (2%), corticosteriod use (2%), and
history of TB (1%).
Table 2 Characteristics of SI
Determinants Total cases Reported
(%)
Sum of
Papers
Clinical Features Total cases Reported
(%)
Sum of
Papers
Morbidities Systemically Unwell
Diabetes 399 (17.9) 30 Fever 1225 (55.1) 36
Cancer 112 (5.5) 19 Weight loss/ Anorexia 173 (7.8) 8
Cardiovascular disease 109 (4.9) 6 Rigours 146 (6.6) 3
Renal failure 56 (2.5) 10 Fatigue or weakness 102 (4.6) 6
Liver disease 40 (1.8) 10 Sweats/Night sweats 76 (3.4) 5
Blood pressure dysfunction 40 (1.8) 6 Active infection 54 (2.4) 1
Rheumatoid Arthritis 35 (1.6) 7 Sepsis/Septic Shock 36 (1.6) 2
Social Factors Pain
Intravenous drug use 210 (9.4) 15 Spinal Pain 1591 (71.5) 36
Corticosteroid use 72 (3.2) 7 Radiculopathy 214 (9.6) 12
Alcoholism 41 (1.8) 8 Tenderness 116 (6.6) 6
Triggers Arthralgia 33 (1.5) 3
Surgery 124 (5.6) 10 Myalgia 23 (1.0) 3
Pre-existing Infection 123 (5.5) 15 Sciatic pain 19 (0.9) 2
Immunosuppression 96 (4.3) 8 Neurological Symptoms
Invasive procedure 42 (1.9) 6 Neurological
dysfunction
739 (33.2) 26
Spinal Trauma 32 (1.4) 6 Limb weakness 175 (7.9) 9
Environmental Factors Para/quadriplegia 51 (2.3) 5
Migrant 70 (3.1) 1 Para/quadriparesis 46 (2.1) 4
Occupational exposure 42 (1.9) 3 Paralysis 46 (2.1) 2
Lived in rural area 28 (1.3) 1 Urological Symptoms
Born in TB endemic country 18 (0.8) 1 Bladder/bowl
dysfunction
62 (2.8) 4
Behavioural Factors Urinary incontinence 21 (0.9) 2
Ingestion of unpasteurised dairy product
61 (2.7)
3 Organ Involvement
Contact with infected animals 29 (1.3) 1 Hepatosplenomegaly 21 (0.9) 4
Predisposing Factors Miscellaneous
None & Miscellaneous 116 (5.2) 8 Constitutional
Symptoms
199 (8.9) 4
History of TB 19 (0.9) 1 Spinal deformity 30 (1.3) 1
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The pathogens reported were Bacterial (n = 1665),
Fungal (n = 12), mixed organism (n = 27) and unknown
growth (n = 82), with the most common microorganisms
being Staphylococcus aureus (27%; n = 598), Mycobacter-
ium tuberculosis (12%; n = 262) and Brucella (9%; n =
210) (Table 3). There were no reports found on the
other potential pathogenic causes of SI i.e. Viral, Prionic
or Parasitic
Discussion
Based on our initial search there were two potential
studies evaluating the diagnostic accuracy of red flags
for SI. However, just based on these two studies it was
not possible to examine the diagnostic accuracy of red
flags for SI, as one study combined the sensitivity and
specificity for fever, spine pain, and neurologic deficits
(classic triad) [54], while the other study, due to the low
prevalence of SI, failed to gauge the sensitivity and speci-
ficity of red flags for SI [35]. This is consistent with the
findings of Verhagen et al. in a recent systematic review
looking at the red flags reported in current low back
pain guidelines [3]. Spinal Infection is a relatively rare
condition with an incidence of 0.2–2.4 cases per 100,000
annually in western societies [55, 56], this low incidence
rate makes it virtually impossible to design a prospective
diagnostic study [30, 32], resulting in a large body of
retrospective case series and case report studies with no
diagnostic accuracy data.
The majority of studies reviewed were carried out
in the secondary care setting with a small number
(5%) in the primary care setting [15, 57]. This under-
lines how difficult it is to identify SI in the early
stages as the onset is insidious, there can be a pro-
tracted prodromal period and the clinical features are
not highly specific, therefore many patients are likely
to have been referred from primary care to secondary
care for a diagnosis.
Determinants
Red flags currently used in clinical practice that are
considered specific to infection are; the use of
corticosteroids, or immunosuppressant therapy,
Intravenous drug abuse, past history of TB and fever
[58, 59]. These, with the exception of fever, are all
related to determinants rather than clinical signs of
infection. The results of this paper concur and all of
these determinants are reported, however, the most
reported determinant was diabetes which featured in
30 papers. Although diabetes appeared as a deter-
minant in a large number of papers it is interesting
that it was only reported in 18% of patients. The re-
view highlights that a number of morbidities such as
diabetes, cancer, and HIV are among those condi-
tions associated with immunosuppression which can
consequently result in a suscebtibility to infection.
Determinants such as corticosteroid use and alcohol
Table 3 Causative Pathogens
Microbiology Total (%) Sum of papers
Bacterial 1665 (74.9) 37
Staphylococcus aureus 598 (26.9) 27
Mycobacterium tuberculosis 262 (11.8) 13
Brucella 210 (9.4) 9
Streptococcus 122 (5.5) 19
Escherichia coli 86 (3.9) 20
Methicillin-resistant Staphylococcus aureus 81 (3.6) 7
Staphylococcus epidermitis 53 (2.4) 9
Psuedomonas 32 (1.4) 13
Methicillin-susceptible Staphylococcus aureus 25 (1.1) 2
Proteus 11 (0.5) 5
Salmonella 10 (0.4) 6
Staphylococcus, coagulase negative 10 (0.4) 4
Other 165 (7.33) 16
Fungal
Candida 12 (0.5) 5
Mixed-growth 27 (1.2) 7
Unknown 82 (3.7) 7
No growth 40 (1.8) 5
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abuse can also lead to a risk of immunodeficiency
[60–63]. Also of note is that diseases such as
rheumatoid arthritis and cancer sufferers treated
with medications known to cause immunodeficiency
(e.g. Disease-modifying anti-rheumatic drugs
(DMARDS), steroids) are also at risk of SI. Determi-
nants for SI (including intravenous drug use, dia-
betes and cancer) have high sensitivity (98%) and
negative predictive value (99%) making them a better
predictor of SI than clinical features such as the
‘classic triad’ (spinal pain, fever and neurological
dysfunction) [54].
Spinal surgery and invasive procedures are regarded as
having a high risk of infection with a rate of 1–4% re-
ported elsewhere [64]. However, in this review, surgery
and invasive procedures were reported as 6 and 2%, re-
spectively. With procedural-induced SI, there are modifi-
able and non-modifiable determinants, such as sterility
and immunological state [65–67]. Furthermore, post-
procedural infection rate is highly linked to the invasive-
ness and complexity of the procedure carried out and
the instrumentation used [68].
The overall mean age for those presenting with SI in
this review was 55 years; previous research supports the
notion that SI is a disease of older people [69, 70]. Ama-
doru et al. specifically looked at differences in presenta-
tion and outcomes between younger and older patients
with SI [13]. Their findings suggested that older patients
with SI present with fewer typical clinical features in-
cluding fever and rigour and tend to seek medical advice
later than younger patients. This could explain why age
is a predictor for medical treatment failure [71]. How-
ever, the older population are also more likely to suffer
from multi-morbidities which can suppress the immune
system making them more susceptible to SI. A past his-
tory of TB is a question routinely asked by clinicians but
it is only mentioned in one paper in this review [72].
Whilst Spinal TB is rare it is on the rise. The incidence
of TB is dependent on birthplace and environmental fac-
tors, for example, born in countries with a high burden
of TB, social conditions such as living in urban over-
crowded conditions and homelessness. However, in this
review, the social conditions reported related to rural liv-
ing and occupational exposure [73].
Clinical features
The most commonly reported features of SI reported in
this review were back pain, fever and neurological dys-
function which has been described elsewhere as the clas-
sic triad [54]. The classic triad is the hallmark of the SI
but reliance on patients presenting with these features is
likely to result in missed cases or diagnosis in the late
stages as not all patients will present with all three fea-
tures. The most common reported symptom in this
review is that of back pain (71%), however, back pain is
usually a benign condition with a prevalence of 80% in
the general population [74], which can present a diag-
nostic challenge for clinicians and in isolation it does
not aid in identifying SI. In primary care, it is often back
pain symptoms that prompt patients to seek help in the
first place. Equally neurological symptoms are also re-
ported but are also prevalent in the general population.
SI is a progressively worsening disease with neurological
deficit occurring in the later stages, whereas in the gen-
eral population the expectation would be that after a
period of time these neurological symptoms would re-
solve. Fever was the second most reported clinical fea-
ture of infection in this review. However, it was only
prevalent in 55% of patients suggesting that a lack of
fever cannot rule out SI and clinicians should not neces-
sarily be reassured by its absence. These findings are
consistent with other literature [70, 75–77], with Davis
et al. reporting the ‘classic triad’ to be 8% sensitive and
99% specific [54].
Clinical presentations
Overall, Staphylococcus aureus was the most reported
cause of SI. Whereas Viral, Prionic and Parasitic causa-
tive pathogens were not reported at all. This is compar-
able with the wider literature as other systematic reviews
also report bacterial SI, in particular, Staphylococcus
aureus, to be the dominant causative SI agent [70, 76].
Though rare and not reported in this review, Viral and
Parasitic SI do exist [78, 79]. In addition to this, Prionic
diseases are even rarer, they are diseases of the nervous
system affecting both humans and animals, there is no
evidence of them affecting the musculoskeletal system,
in particular, the spine [80].
Diagnosis
Despite their low sensitivity (between 43 and 75%) [81],
plain radiographs have traditionally been considered as
the first step for assessing vertebral destruction [82, 83].
CT and MRI scans are highly sensitive, the results in this
review show that CT and MRI scans were the most ac-
curate radiological tests for diagnosing SI. Though, it is
suggested that CT scans fail to properly detect epidural
abscesses and spinal cord lesions, as such they are the
procedure of choice only when MRI cannot be per-
formed [82]. Finally, due to its diagnostic accuracy and
non-invasive nature, MRI is the imaging of choice when
investigating suspected SI, in particular, the early stages.
MRI sensitivity, specificity, and accuracy for detecting SI
are reported as 96, 92, and 94%, respectively [83–86].
Nevertheless, advanced diagnostic tools such as MRI
and CT scans are costly and less available in primary
care and low-income settings [87, 88], using them as the
first diagnostic step for back pain patients is inefficient
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and wasteful. Therefore, it is important and cost-
effective for clinicians to be equipped with the red flags
to screen and decide whether further diagnostic tests are
needed [87]. In one of the studies reviewed, Ferrari
looked at the outcome of patients with spinal pain who
were not referred to advanced imaging unless they pre-
sented with red flags, he found that using red flags as
the threshold before ordering advanced imaging has a
low threshold for missing serious spinal pathology [31].
Limitations
To the author’s knowledge, this is the first review to in-
vestigate the use of red flags to identify SI. This review
has identified gaps in research and knowledge and rec-
ommends future areas of research [89]. Our findings
should be understood in the context of some limitations.
Firstly, as we were not able to identify studies presenting
diagnostic accuracy of red flags for spinal infection, as a
result, we presented a descriptive review of the charac-
teristics of people with spinal infection. As there was no
control group to facilitate comparison of different deter-
minants and clinical features, we do not know whether
many of these features were more common in people
with spinal infection compared to those without. As
these results only tell us what features are common in
people with spinal infection, they cannot be relied upon
for diagnosis. Secondly, most of the studies included in
this review were from high income (HI) countries, yet
the global burden of infections such as Spinal TB falls
mostly on low income and low middle-income countries
(LMI); countries where TB, Brucellosis and HIV are en-
demic [90]. This might suggest selection bias (Table 1)
but may also be as a result of underdiagnoses and
underreporting of SI in LMI countries. LMI countries
tend to have weak public health infrastructure and poor
health-care research capacity compared to HI countries
[91]. Furthermore, the disparity in the burden of disease
in LMI countries and HI means efforts and resources
are prioritised to different diseases [92]. Though the po-
tential for publication bias must not be ruled out, there
is also some research alluding to the possibility of an
editorial bias against the academic output from low-
income countries [93, 94].
Recommendations
The current evidence surrounding red flags for SI re-
mains of low quality and clinical features alone should
not be relied upon to identify SI. When a patient arrives
in clinic understanding determinants of possible SI
should initially be considered. These risks include im-
munosuppression due to co-morbidities or drug use and
environmental factors (surgery and social circum-
stances). The prevalence of these determinants com-
bined with the presentation of clinical features of spinal
pain with possible neurological dysfunction and fever
should lead to a lowered threshold (or heightened index
of suspicion) to further investigate and diagnostic tests
should be performed to rule out SI. MRI is the imaging
technique of choice when investigating suspected SI.
The authors, therefore, suggest grouping red flags into a
priori and a posteriori. The a priori red flags being the
comorbidities and determinants that may be present
leading to the development of SI, and the a posteriori
being the signs symptoms and clinical features that are
present after the onset of SI. Temporally stratifying red
flags in this manner will aid the clinician in building a
picture based on both potential risk of SI and presenta-
tion consistent with SI.
Conclusion
Due to the paucity of literature on red flags for spinal in-
fection, it was not possible to assess the diagnostic ac-
curacy of red flags for spinal infection, as such, the
authors conducted a descriptive review reporting the
characteristics of those presenting with spinal infection
was carried out. Based on the reviewed studies, spinal in-
fection was common in those who had conditions asso-
ciated with immunosuppression. Additionally, the most
frequently reported clinical feature was the classic triad
of spinal pain, fever and neurological dysfunction.
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